Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2025 HSCA National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Congressional Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices

March 12, 2025 by samuelfreund Federal Comments 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on ways to strengthen U.S. trade policy and domestic production.

 

Click here to view the full response.

Prev
Next

Related Posts

HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
February 5, 2021

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Comments on FDA Draft Guidance for Drug Supply Chain Security Act (DSCSA) Standards
November 9, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Comments on FDA “Risk Management Plans to Mitigate the Potential for Drug Shortages” Draft Guidance
August 22, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance
June 5, 2023

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more

Our Office

Healthcare Supply Chain Association
750 9th Street NW, Suite 650
Washington, DC 20001

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Statement on Recent Executive Order to Promote Domestic Production of Critical Medicines
    May 20, 2025
  • HSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
    May 8, 2025